Aug 2026· Journal of Translational Autoimmunity· Vol 13, pp. 100391· 0 citations· 59 references
Medicine
TL;DR
This Review proposes immunometabolic set points as an integrative framework for examining how immune-cell metabolic programs, tissue metabolic niches, metabolite signaling, and immune or metabolic memory may interact in chronic autoimmune disease and distinguishes evidence-supported mechanisms from broader conceptual inferences concerning relapse-prone remission and therapeutic reset.
Abstract
Autoimmune diseases often persist despite effective suppression of overt inflammation, and many patients experience relapse after treatment tapering or withdrawal. This clinical pattern raises the possibility that disease activity is influenced not only by ongoing immune stimulation, but also by relatively stable biological states that preserve inflammatory potential. In this Review, we propose immunometabolic set points as an integrative framework for examining how immune-cell metabolic programs, tissue metabolic niches, metabolite signaling, and immune or metabolic memory may interact in chronic autoimmune disease. Rather than representing a single pathway or biomarker, an immunometabolic set point is proposed to describe a potentially reversible multicompartment state shaped by immune and tissue interactions. Experimental studies support important roles for cellular metabolism, local nutrient and oxygen conditions, mitochondrial stress, stromal activation, and metabolites such as lactate, succinate, and itaconate in regulating immune function. However, their integration into a unified disease-maintaining state has not been directly established. We therefore distinguish evidence-supported mechanisms from broader conceptual inferences concerning relapse-prone remission and therapeutic reset. We further discuss how longitudinal single-cell profiling, spatial omics, metabolomics, and metabolic flux analysis may be used to test the framework and determine whether treatment produces transient inflammatory suppression or more durable biological reconfiguration.
Immunometabolism has become a central mechanism governing innate and adaptive immune responses. The field has moved from cataloguing metabolic shifts during immune activation to understanding how specific pathways control immune cell fate and function. This review brings together current knowledge on immunometabolic re...
Autoimmune diseases represent a major and growing health burden, particularly among young adults. Emerging evidence suggests that changes in the environment and diet may contribute to disease. Experimental studies have demonstrated that excessive salt intake can modulate immune function by inducing pathogenic pro‐infla...
V. Driessen, Margarita Dominguez-Villar, D. Hafler et al.· European Journal of Immunolo...· 0 citations
How changes in glucose, lipid, and mitochondrial metabolism influence immune responses that lead to chronic inflammation and autoimmunity in MS, RA, and T1D is discussed.
Andisheh Mosaffa Jahromi, Fatemeh Mirzaei, Sara Mirzazadeh et al.· Cellular & Molecular Immunol...· 1 citation
While smoking cessation must likely be absolute to reverse pathogenic trafficking signals (such as GPR15 upregulation), the linear effect of BMI suggests that incremental weight loss confers proportional immunologic benefits, which strongly support the integration of lifestyle interventions as a core component of early...
Simon Falk, A. Schulte-Mecklenbeck, P. Ostkamp et al.· Neurology(R) neuroimmunology...· 0 citations
Chronic liver disease develops through sustained interactions among metabolic stress, environmental exposure, immune activation, and tissue remodeling. These processes are often studied as separate domains, yet in patients they converge within the same hepatic microenvironment and help explain why disease trajectories...
Hai-Lin Wang, Qi Tang, Juan Hu et al.· Frontiers in Immunology· 0 citations
ABSTRACT Immune-mediated kidney diseases have a substantial disease burden and frequent disease relapses significantly contribute to the high morbidity. Relapsing disease courses are associated with poor outcome and accelerated progression to end-stage renal disease. The pathomechanisms leading to relapse are diverse a...
Malte Hellmig, Christian F. Krebs· Clinical Kidney Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.